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ReviewGlossary
Autophagosomes: double-membrane-surrounded organelles that form in the
endoplasmic reticulum (ER) in response to cellular stress (e.g. nutrient
depletion). Their main role is to target substrates to the lysosomes for
degradation.
ß-oxidation: generates energy from degradation of fatty acids. In a single ß-
oxidation cycle the fatty acid chain is shortened by two carbons to generate a
molecule of acetyl-CoA. The acetyl-CoA can enter the tricarboxylic acid (TCA)
cycle to generate ATP.
Fatty acids: carboxylic acids (-COOH) with a long tail composed of chains of
carbon atoms. Depending on the chain length, fatty acids can be classified as
short (<6 carbon atoms), medium (6–12), long (12–21) or very long (>22).
Gluconeogenesis: the metabolic reaction triggering the biosynthesis of
glucose from pyruvate, lactate, glycerol and the amino acids alanine and
glutamine.
Ketone bodies: produced by the liver during fasting and from fatty acid
catabolism after prolonged exercise. They are used peripherally as an energy
source when glucose is not available. The three types of ketone bodies are
acetone, acetoacetic acid and beta-hydroxybutyric acid.
Lipases: hydrolytic enzymes that catalyze the degradation of fats by hydrolyz-
ing their ester bonds such as those between glycerol and fatty acid chains.
Lipid droplets: intracellular organelles that store neutral lipids, such as
triacylglycerols and sterol esters (including cholesterol).
Lipogenesis: the generation of fatty acids from acetyl-CoA. It is activated under
fed conditions by insulin signaling and by mechanistic target of rapamycin
complex 1 (mTORC1) kinase.Autophagy is a catabolic pathway that has a fundamen-
tal role in the adaptation to fasting and primarily relies
on the activity of the endolysosomal system, to which
the autophagosome targets substrates for degradation.
Recent studies have revealed that the lysosomal–autop-
hagic pathway plays an important part in the early steps
of lipid degradation. In this review, we discuss the
transcriptional mechanisms underlying co-regulation
between lysosome, autophagy, and other steps of lipid
catabolism, including the activity of nutrient-sensitive
transcription factors (TFs) and of members of the nuclear
receptor family. In addition, we discuss how the lyso-
some acts as a metabolic sensor and orchestrates the
transcriptional response to fasting.
Overview of lipid catabolism pathway during fasting
Nutrient deprivation is one of the harshest conditions that
an organism may face. To sustain cellular metabolism,
lipids, proteins, and carbohydrates must be degraded to
give rise to fatty acids (FA), amino acids (AA), and pyru-
vate, respectively (see Glossary). These substrates can in
turn generate ATP to sustain energy [1]. Specifically, lipids
such as triglycerides (TGs) can be broken down through
various mechanisms including lipolysis and autophagy
during times of nutrient deprivation.
TGs are the predominant form of fat in the human body
and are composed of three chains of FA linked to one
molecule of glycerol. TGs are normally stored in specialized
organelles named lipid droplets (LDs), which also contain
esterified cholesterol. LDs originate from the membrane of
the endoplasmic reticulum and are delimited by a monolay-
er of phospholipids and coated with structural proteins such
as perilipins, caveolins, and several members of the Rab
family of small GTPases. LDs are the main cytosolic compo-
nent of adipocytes and are found in virtually every cell type,
such as hepatocytes, neurons, glia, macrophages, dendritic
cells, and lymphoblasts [2,3]. LDs were traditionally
thought to be hydrolyzed by three lipases: LD-associated0962-8924/
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sensitive lipase (HSL); and monoacylglycerol lipase (MGL),
which are all regulated by nutrients and hormonal levels [4].
However, in most non-adipose tissues these lipases exhibit
low expression levels, raising the question as to whether
other lipases are required for efficient lipolysis.
Nutrient deprivation triggers the breakdown of TGs,
which are contained in LDs, into glycerol and FA. In
adipose tissue, these intermediates are secreted into the
bloodstream, whereas in non-adipose tissues they are oxi-
dized in mitochondria and peroxisomes via the ß-oxidation
pathway, which splits long carbon chains of FA into mole-
cules of acetyl-CoA, an important substrate for the tricar-
boxylic acid (TCA) cycle [2,4]. Several proteins facilitate
the cellular import of FA, including the plasma membrane
FA translocase CD36. Once in the cytosol, FA are esterifiedLysosomes: cellular organelles, containing several classes of hydrolytic
enzymes, which are deputed to the degradation of a large repertoire of cellular
substrates.
TCA cycle: (also Krebs cycle or citric acid cycle) is a series of enzyme-catalyzed
chemical reactions occurring in mitochondria that generate energy (ATP)
through the oxidation of acetate derived from carbohydrates, fats and proteins.
Triglycerides: fat molecules composed of a sugar alcohol (glycerol) linked to
three molecules of fatty acids through ester bonds between the hydroxide
groups of the glycerol and the carboxyl group of the fatty acid.
Trends in Cell Biology, December 2014, Vol. 24, No. 12 743
Box 1. Overview of the autophagy pathway
The autophagy pathway relies on the activities of two organelles:
the autophagosome (AV) and the lysosome. AVs are involved in
intracellular cargo sequestration and delivery to the lysosomes,
initiating the degradation steps. AVs are double-lipid-bilayer
membrane vesicles that originate from several membrane sources
including the endoplasmic reticulum (ER), mitochondria, Golgi, and
plasma membrane [75]. The biogenesis of the isolation membrane
occurs mainly at the ER–mitochondria contact sites [76]. During
membrane expansion, substrates are sequestered through receptor-
mediated mechanisms before membrane sealing. Mature AVs fuse
with lysosomes, forming autophagolysosomes, hybrid vesicles in
which the degradation of the autophagic cargo occurs. Lysosomes
are single-lipid-bilayer membrane organelles with an acidic lumen
containing soluble hydrolytic enzymes, which are the executors of
the catabolic processes. They include members of protein families
such as sulfatases, glycosidases, peptidases, phosphatases, lipases,
and nucleases that allow the lysosome to hydrolyze a vast repertoire
of biological substrates, including proteins, glycosaminoglycans,
lipids, glycogen, and nucleic acids [77]. Fasting leads to an increase
in the number and size of AVs and lysosomes, suggesting that the
cell has evolved a mechanism to co-regulate biogenesis and
function of these two organelles to respond to fasting [27].
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palmitoyl transferase I and II (CPTI and CPTII) and carni-
tine acyltransferase enzymes. These modifications enable
FA to move across the inner mitochondrial membrane. The
import of FA into mitochondria is considered a rate-limiting
step of the ß-oxidation pathway. Once inside the mitochon-
dria a molecule of FA is degraded through cyclic reactions
that shorten their chain length by two carbons per cycle,
generating FADH2 and NADH molecules. This process is
mainly mediated by acyl-CoA synthetase, long- and medi-
um-chain acyl-CoA dehydrogenases, and 3-ketoacyl-CoA
thiolase. ß-oxidation of very long FA chains may also occur
within peroxisomes.
The expression and activity of key metabolic enzymes
and transport proteins involved in lipid catabolism are
tightly regulated by transcriptional and post-transcrip-
tional mechanisms, which are mediated by endocrine,
paracrine, and autocrine signals. The transcriptional
regulation of lipid catabolism in liver and skeletal muscle
is mainly controlled by the activities of the nuclear re-
ceptor peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PPARa) and of its co-activator
PGC1a, which are significantly induced during fasting
[5]. PPARa regulates intracellular lipid metabolism
through direct transcriptional control of many genes
involved in peroxisomal and mitochondrial b-oxidation
pathways, FA uptake, and TG catabolism including
CD36, CPT-1, and HMG-CoA synthase, which converts
acetyl-CoA units into ketone bodies [84]. Emerging evi-
dence suggests a link between these lipid catabolism
pathways and nutrient deprivation, which is reviewed
in further detail below.
Lipophagy: a vesicular way to degrade fat
In recent years, the intracellular process known as macro-
autophagy (hereafter autophagy) has emerged as a critical
regulator of energy metabolism during fasting [6]
(Figure 1). Autophagy is an evolutionarily conserved cata-
bolic process involved in the first steps of the degradation of
intracellular components, such as proteins and glycogen,
which yield AA and glucose, respectively (Figure 1) [7].
Consequently, autophagy sustains energy productionProteins
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Figure 1. Autophagy mediates substrate catabolism during fasting. During
nutrient deprivation proteins, glycogen and fat are sequestered by
autophagosomes and targeted to lysosomes where they are degraded by
resident hydrolases and transformed into amino acids, fatty acids, and glucose,
which are then released into the cytoplasm to support cellular energetic demands.
Abbreviations: AV, autophagosome; LYS, lysosome.
744when extracellular nutrients are not available. A brief
overview of the autophagic pathway is described in Box 1.
Autophagy has recently been shown to be involved in
lipid catabolism and has been termed lipophagy to refer to
the specific degradation of lipids by autophagy [8]
(Figure 1). Indeed, in cells lacking an essential autophagy
gene, LDs accumulate in the cytoplasm due to defective
catabolism [8], suggesting that it takes a functional autop-
hagic pathway to break them down. Studies performed in
cultured hepatocytes showed that autophagosomes seques-
ter portions of LDs and target them to lysosomes for
degradation. This process may also occur in vivo, because
it was observed that cells of patients affected by liver
steatosis contain lipid-filled lysosomes [9]. In liver, lipo-
phagy participates in constitutive lipid degradation. How-
ever, its maximal contribution appears to be during
fasting, when the liver imports an increased amount of
lipids derived from peripheral lipolysis [8]. Mice deficient
in several key autophagy genes such as ATG5, ATG7,
ATG14 and VPS34 show elevated TG levels in the liver
[8,10–12]. In addition, several studies have demonstratedIn the past few years great progress has been made to understand
the molecular mechanisms governing autophagy [78]. Briefly, a core
set of essential autophagy proteins (ATG) and several accessory
proteins, such as soluble N-ethylmaleimide-sensitive factor attach-
ment protein (SNAP) receptors (SNAREs), vacuolar protein sorting-
associated protein (VPSs), and RABs, are required for AV biogen-
esis. Their physiological activities are connected to the energy
status of the cell by nutrient-sensitive proteins. For example, the
mechanistic target of rapamycin complex 1 (mTORC1) kinase and
the AMP-activated protein kinase (AMPK), which sense the cellular
levels of nutrients, inhibit or activate autophagy, respectively,
through phosphorylation of the mammalian homolog of yeast
adipose triglyceride (ATG)1 [Unc-51 like autophagy activating kinase
1 (ULK1)] kinase [79–81]. ULK1, in turn, controls the activity of the
protein complexes composed of ATG13, FIP200, and ATG101 and of
the Beclin1/class III phosphatidylinositide 3-kinase (PI3K) VPS34,
which produces the phosphatidylinositol 3-phosphate (PI3P) neces-
sary for AV membrane formation [82]. Another example is the
fasting-induced activation of the c-Jun N-terminal kinase (JNK)/
mitogen-activated protein (MAP) kinase, which phosphorylates B
cell leukemia factor 2 (Bcl-2) and triggers its dissociation from
Beclin1, which activates autophagy [83].
Review Trends in Cell Biology December 2014, Vol. 24, No. 12that lipophagy also occurs in other tissues and cell types,
including fibroblasts, neurons, stellate cells, and macro-
phages [13,14].
Furthermore, it has been suggested that intracellular
accumulation of LDs may promote autophagy, because
LDs provide lipid precursors for the nascent autophago-
some membrane. Mechanistically, the LD membrane-as-
sociated patatin-like phospholipase domain-containing
proteins (PNPLAs) mobilize TGs to form diacylglycerol
(DAG), which is used to build phospholipids necessary
for autophagosomal membrane formation [15].
In mammals, lysosomes contain a single lysosomal acid
lipase (LAL) [16], which is mainly active at an acidic pH
and mediates lysosomal degradation of TGs, endocytosed
lipoproteins, and membrane lipids. LAL deficiency causes
Wolman disease (known as cholesteryl ester storage dis-
ease in its milder form), a severe lysosomal storage disor-
der (LSD) characterized by the storage of lipids in various
organs, including liver and brain [17,18]. During lipo-
phagy, LAL mediates the hydrolysis of cholesterol esters,
which are delivered from LDs to lysosomes via autophagy
[19,20]. In addition, Caenorhabditis elegans strains lacking
the ce-lysosomal lipases LIPL-1 and LIPL-3 (for which only
one lipase exists in mammals) accumulate LDs as a result
of their defective degradation, further suggesting that
lysosomal lipases have an important role in fat degrada-
tion [21].
The way in which lipophagy is regulated and connected
to other lipid catabolic pathways like the intracellular
uptake of lipid from the bloodstream and ß-oxidation in
mitochondria is still unclear. These processes must be co-
regulated to optimize lipid usage during fasting and pre-
vent the lipotoxicity associated with the accumulation of
lipids in the cytosol.
In this review, we discuss the evidence suggesting that
lipophagy is a transcriptionally regulated process and
propose that a gene network links lipophagy to other
pathways of lipid catabolism. In addition, we hypothesize
that regulation of lipophagy during fasting occurs through
a signaling pathway triggered by the lysosome. This path-
way requires the coordinated activities of the mechanistic
target of rapamycin complex 1 (mTORC1), of nutrient-
sensitive transcription factors (TFs), and of members of
the nuclear receptor family.
A transcriptional hypothesis for the regulation of
lipophagy
Until recently, autophagy regulation was thought to occur
exclusively in the cytosol. This dogma was set forth after
enucleated cells showed accumulation of LC3 puncta in
response to an autophagic stimulus [22]. However, recent
reports have challenged this view and have provided evi-
dence for transcriptional and epigenetic control of autop-
hagy. The list of TFs implicated in the regulation of
autophagy has continued to grow [23]. Furthermore, micro-
RNAs and epigenetic mechanisms have added an addition-
al layer of complexity to autophagy regulation [24].
Transcriptional regulation coordinates complex meta-
bolic processes, such as the multistep pathways that
occur within cellular organelles [25]. In the nematode
C. elegans the transcriptional regulation of autophagyoccurs concomitantly with transcriptional induction of
lipolysis [26], suggesting that the two processes can be
co-regulated by the activity of TFs. In mammals, transcrip-
tion factor EB (TFEB), tumor suppressor protein 53 (p53),
and members of the forkhead box protein class O (FOXOs)
are emerging as master transcriptional regulators of
autophagy [23]. Importantly, these TFs are regulated by
nutrients and growth factor levels and, in turn, regulate
the expression levels of genes involved in energy metabo-
lism. This regulation occurs either directly or via coopera-
tion with members of the nuclear receptor and co-receptor
families, which are master regulators of energy metabo-
lism and lipid catabolism. These observations suggest that
these TFs regulate lipophagy and coordinate it with other
pathways of lipid catabolism.
TFEB links lipophagy to b-oxidation via nuclear
receptors
Among the TFs involved in autophagy, TFEB appears to
exert the most global control over autophagy [27]. Indeed,
it regulates multiple steps of autophagy, such as autopha-
gosome biogenesis, substrate targeting, and lysosome deg-
radation, by managing expression levels of several
autophagy and lysosomal genes [28].
TFEB belongs to the microphthalmia-associated tran-
scription factor (MITF) subfamily of basic helix-loop-helix
(bHLH) TFs [29]. The gene network controlled by TFEB
was named coordinated lysosomal expression and regula-
tion (CLEAR) [30] and includes several genes with a known
role in autophagy and lysosome biogenesis [27,28]. LAL is
among TFEB targets, suggesting that TFEB activation
may promote lysosomal degradation of lipids [28]. Func-
tional studies indicate that TFEB induces de novo biogen-
esis of autophagosomes and lysosomes, enhances their
fusion, and increases the degradation of substrates. In
addition, TFEB enhances other lysosomal functions such
as lysosomal exocytosis [31,32].
Under normal feeding conditions TFEB is retained in
the cytosol, whereas during fasting it translocates to the
nucleus and becomes active [27]. mTORC1, a key regulator
of TFEB, phosphorylates TFEB at conserved serine resi-
dues, preventing its nuclear translocation. Nutrient depri-
vation inhibits mTORC1, thus promoting TFEB nuclear
translocation and transcriptional activation of the CLEAR
gene network [33–35].
The transcriptional changes induced by TFEB overex-
pression in the liver are similar to those observed after
fasting, suggesting that TFEB mediates the fasting re-
sponse [36]. In particular, TFEB regulates the expression
of genes involved in several steps of lipid degradation, such
as the intracellular import of FA across the plasma mem-
brane [e.g., CD36 and fatty acid binding proteins (FABPs)]
and the b-oxidation of FA in mitochondria [e.g., Cpt1,
carnitine acetyltransferase (Crat), acyl-CoA dehydroge-
nase, long chain (Acadl), acyl-CoA dehydrogenase, C-2
To C-3 short chain (Acads)] and in peroxisomes (CYP4a)
[36]. Furthermore, TFEB controls the expression of PGC1a
and PPARa genes, which are known master regulators of
lipid catabolism. Indeed, during fasting nuclear TFEB
binds to the promoters of PGC1a [36] and PPARa (Set-
tembre, C. and Ballabio, A., unpublished) and increases745
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Figure 2. Proposed model of coordinated transcriptional regulation of lipid
catabolism via forkhead box protein class O (FOXO), transcription factor EB
(TFEB), p53, and nuclear receptors. The nuclear translocation of TFEB, p53, and
FOXOs is induced under conditions of metabolic stress such as nutrient depletion
and growth factor deprivation. These transcription factors (TFs) regulate directly
the expression of autophagy genes and the nuclear receptor and co-receptor
peroxisome proliferator-activated receptor (PPAR)a and peroxisome proliferator-
activated receptor gamma coactivator 1-alpha (PGC1a), respectively, which control
lipid catabolism.
Review Trends in Cell Biology December 2014, Vol. 24, No. 12their expression levels. Conversely, mice lacking TFEB in
the liver show a defective fasting response probably be-
cause they lack PGC1a upregulation. Genetic interaction
studies have revealed that TFEB activity depends on the
presence of PGC1a and PPARa [36], hence suggesting that
these nuclear receptors are involved in the regulation of
autophagy and lysosomal biogenesis. Consistently, over-
expression of PGC1a in muscle increases the number of
autophagosomes and lysosomes [37]. Furthermore, TFEB
overexpression in the liver of mice lacking the essential
autophagy gene ATG7 fails to induce lipid catabolism and
results in the accumulation of LDs in the cytosol of hepa-
tocytes [36], indicating that TFEB requires a functional
autophagic pathway to have an effect on lipid catabolism.
This finding clearly indicates that lipid catabolism requires
functional autophagy.
TFEB controls lipophagy in vivo
The phenotypic consequences of TFEB overexpression in
mice are striking. Mice overexpressing TFEB in the liver
are leaner and show enhanced whole-body energy metabo-
lism and FA catabolism. Cholesterol levels were not signifi-
cantly altered in TFEB-overexpressing mice and
consequently the role of TFEB in the regulation of cholesterol
metabolism was not investigated. Mice overexpressing TFEB
in liver are protected from diet-induced obesity and metabolic
syndrome. Conversely, mice lacking TFEB in the liver display
accumulation of LDs in the cytoplasm of hepatocytes, which is
consistent with defective lipophagy, and defective peripheral
fat mobilization after fasting [36]. Peripheral organs are also
affected probably due to enhanced transcription of liver-
derived hormones regulating lipid catabolism, such as fibro-
blast growth factor (FGF)21. FGF21 is directly induced by
PPARa in the liver in response to fasting. In addition, it
promotes weight loss, lowers blood levels of glucose and
triglycerides, increases insulin sensitivity, and stimulates
lipolysis in white adipose tissue [38]. FGF21 has been recent-
ly linked to autophagy [39]. Inhibiting autophagy in skeletal
muscle was proposed to ameliorate whole-body energy me-
tabolism through FGF21 upregulation. As a consequence of
defective autophagy, mitochondrial dysfunction activates the
TF ATF4, which in turn enhances FGF21 levels [39]. Al-
though these data are difficult to reconcile with those dem-
onstrating that autophagy maintains a positive role in lipid
metabolism, they suggest that transcriptional crosstalk
exists between autophagy, lipid metabolism, and nuclear
receptors.
In addition, recent studies performed in C. elegans sug-
gest TFEB may have a role in longevity. Indeed, a C. elegans
mutant strain lacking the TFEB orthologous gene (HLH30)
showed that HLH30 mutant animals fail to degrade LDs
during starvation and have decreased lifespan [21,40]. In
the worm HLH30 promotes lysosomal biogenesis and autop-
hagy and mediates lysosomal lipolysis through the upregu-
lation of the lysosomal lipases LIPL-1 and LIPL-3. When
nutrients are available, transcription of LIPL-1 and LIPL-3
is repressed by the transcriptional repressor MLX-3. During
fasting MAX-like protein X (MLX-3) is rapidly degraded,
and HLH30 is activated [21]. Consistent with lipid metabo-
lism and autophagy as determinants of C. elegans longevity
[41], HLH30 overexpression extends the lifespan of746C. elegans [40]. Collectively, these data suggest that TFEB
coordinates lipophagy with other lipid degradation path-
ways in response to starvation (Figure 2).
Unconventional role of p53 in autophagy and lipid
metabolism
p53 is a tumor suppressor protein that is activated in
response to several types of cellular stress. Activated p53
can induce cell cycle arrest, DNA repair, senescence, and
apoptosis [42]. In the past few years, it has become evident
that activated p53 induces lipid catabolism [43]. Indeed, p53
directly controls the expression levels of genes involved in
FA b-oxidation (CYP4F) and transport (CPT1A, CROT)
[44]. In addition, p53 regulates LIPIN1 protein, which
exerts a profound effect on lipid metabolism. LIPIN1 is a
phosphatidic acid phosphatase that converts phosphatidic
acid to diacylglycerol. In the nucleus, LIPIN1 functions as a
transcriptional co-activator and induces PPARa expression
[45]. In addition, it represses the transcriptional activity of
sterol regulatory element-binding proteins (SREBPs), the
master TFs controlling TG and cholesterol biosynthesis,
thus inhibiting lipid biosynthesis [46]. During glucose dep-
rivation, p53 also promotes PGC1A1a activity [47], suggest-
ing that in the absence of glucose p53 may induce a
metabolic shift toward lipid usage.
p53 is a well-defined transcriptional regulator of autop-
hagy. Originally, it was found to induce autophagy via the
lysosomal protein DNA-damage regulated autophagy mod-
ulator 1 (DRAM1) [48]. More recently, global genomic
profiling has revealed that p53 directly regulates the ex-
pression of several autophagy genes such as ATG7, ATG4,
ULK1 and UVRAG [49]. Furthermore, p53 controls the
transcriptional levels of tuberous sclerosis complex and
phosphatase and tensin homolog (PTEN) [50], which reg-
ulate autophagy indirectly via mTORC1.
These observations suggest that p53 may be involved in
lipophagy, by simultaneously inducing autophagy and FA
oxidation. Human Chang liver cells challenged with oleic
Review Trends in Cell Biology December 2014, Vol. 24, No. 12acid (OA), a monounsaturated FA, display increased levels
of LC3II, lysosomal-associated membrane protein 1
(LAMP1), Beclin1, and ATG5 proteins and accumulation
of OA in the lysosomes, suggesting an induction of lipo-
phagy. Consequent to OA supplementation, pharmacolog-
ical inhibition of p53 with pifithrin-a inhibits the activation
of lipophagy and increases markers of cellular toxicity [51].
Although preliminary, these data support an essential role
of p53 in lipophagy (Figure 2).
FOXOs link autophagy to energy metabolism
FOXO proteins are a family of TFs that integrate informa-
tion from multiple upstream signals and enable tissue
homeostasis during stress [52]. FOXOs activate protein
catabolism by inducing two major protein degradation
systems, the ubiquitin/proteasome and the autophagic/
lysosomal pathways [53,54].
FOXO3-induced autophagy has been studied in the con-
text of muscle wasting following starvation or denervation
and, more recently, during nutrient depletion in hemato-
poietic stem cells [55]. Upon nuclear translocation, FOXO3
binds the promoters of several autophagy genes [54,56],
including the main mediator of FOXO3a pro-autophagic
activity BNIP3, a member of the Bcl2/adenovirus E1B 19
kd-interacting protein (BNIP) family. BNIP3, through its
BH3 domain, interacts with Bcl-2, promoting its dissocia-
tion from Beclin1 [57]. In addition, BNIP3 regulates mito-
chondria clearance via autophagy (mitophagy) through its
LC3-interacting region (LIR) [58]. FOXO3a can also induce
autophagy indirectly via the upregulation of glutamine
synthetase, which inhibits mTORC1 activity by increasing
cellular levels of glutamine [59]. In addition to FOXO3, the
regulation of autophagy by FOXO1 has been linked to cancer
progression [60]. The mechanism by which FOXO1 induces
autophagy is less-well-defined and it appears to involve
transcriptional independent mechanisms. For example, in
the cytosol acetylated FOXO1 binds and activates the autop-
hagy protein ATG7 [60].
FOXO proteins have a crucial role in regulating energy
metabolism. FOXO activity depends on the insulin/phos-
phatidylinositide 3-kinases (PI3K)/AKT pathway. Phos-
phorylation of FOXOs by AKT, a serine/threonine kinase
AKT, leads to their cytosolic retention. Fasting inhibits the
insulin/PI3K/AKT pathway and induces nuclear translo-
cation and activation of FOXO proteins [52]. FOXOs regu-
late glucose homeostasis by promoting gluconeogenesis
and contribute to the ability of tissues to transition from
glucose to lipid metabolism, when a fuel-source is needed
during fasting [52,61]. Indeed, activated FOXOs interact
with nuclear receptors, such as PGC1a and PPARa, thus
supporting induction of gluconeogenenesis, FA oxidation,
and ketone body production. Notably, FOXOs can directly
induce PGC1a expression [62]. Hence, FOXO factors con-
comitantly activate autophagy and promote lipid usage.
FOXO1/3/4 liver-specific knockout mice develop hepatic
steatosis and hypertriglyceridemia and display decreased
autophagic flux. Importantly, this liver phenotype can be
reverted if autophagy is activated by overexpression of the
autophagy gene ATG14 [12]. These data strongly support
the notion that lipophagy is an integral part of FOXO-
mediated induction of lipid metabolism. In adipocytes,FOXO1 controls the expression of LAL during starvation
[63], suggesting that FOXO1 can also enhance the capacity
of the lysosome to degrade TGs (Figure 2).
The lysosome as a sensor for lipophagy induction
Lipophagy is activated during starvation, suggesting that
cells have developed a mechanism to regulate this selective
form of autophagy in response to nutrient availability, or
lack thereof. The nutrient-sensing machinery that triggers
lipophagy in response to starvation has not been charac-
terized yet. Here, we discuss the evidence suggesting a role
for the lysosome as a nutrient-sensing organelle able to
trigger lipophagy.
For years, the lysosome has held the reputation of the
cell’s housekeeper, specifically for the degradation of cel-
lular debris. However, recent data showed that the cell
monitors lysosomal content to gather information on its
energy status. Specifically, the cell can sense the luminal
levels of lysosomal AA and conveys this information to the
cytosolic side [64]. A key player in this nutrient-sensing
machinery is the mTORC1 kinase, which plays a central
part in regulating the equilibrium between anabolic and
catabolic processes [65]. mTORC1 associates with the
lysosomal surface to become activated. This association
is mediated by a growing list of components, including the
lysosomal vacuolar adenosine triphosphatase (v-ATPase),
the Ragulator complex, and the RAS-related GTP-binding
protein (RAG) family of small GTPases (RagA/B and RagC/
D). AA in the lumen of the lysosome send signals to
Ragulator, which exerts guanine nucleotide exchange fac-
tor (GEF) activity on Rags. In their GTP-loaded status,
Rags recruit mTORC1 to the lysosomal surface where it
interacts with the GTP-binding protein Rheb and becomes
active [66]. The proton pump channel v-ATPase transfers
the signal from inside the lysosome to the surface of the
lysosomal membrane [64]. These findings suggest that the
cell influences its metabolic fate by analyzing the products
that arise from lysosomal catabolism. When AA concen-
tration decreases inside the lysosome, mTORC1 is inhib-
ited [64]. Active mTORC1 inhibits PPARa by promoting its
interaction with nuclear receptor co-repressor 1 (nCoR1)
[67] and inhibits TFEB via direct phosphorylation. Hence,
as a consequence of mTORC1 inhibition, FA b-oxidation
and lipophagy are activated. This regulatory mechanism,
which begins at the lumen of the lysosome, may ensure the
generation of energy from the oxidation of lipids when AA
levels become insufficient (Figure 3).
Thus, the lysosome is emerging as a central regulator of
cellular metabolism, controlling intracellular signaling via
mTORC1 and TFEB regulation of several downstream
effectors (Figure 2). The physiopathological contribution
of this lysosome-to-nucleus signaling mechanism [35] is
still unknown; however, one may imagine that perturbing
this regulatory machinery would contribute to the onset of
common pathological conditions that characterize the pro-
cesses of aging and obesity. Indeed, in aged and obese mice,
mTORC1 seems to be hyperactivated and less sensitive to
nutrient fluctuations [67,68]. Consistently, the expression
levels of genes involved in autophagy and in lipid degra-
dation processes are downregulated [10,69], probably due
to sustained inhibition of PPARa and TFEB. Intriguingly,747
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Figure 3. The lysosome as a regulator of lipid metabolism. In the fed state (upper panel), the presence of lysosomal amino acids (AA), glucose, and growth factors induces
activation of mechanistic target of rapamycin complex 1 (mTORC1) on the lysosomal membrane. Active mTORC1 transcriptionally induces lipogenesis and adipogenesis by
activating SREBPs and peroxisome proliferator-activated receptor (PPAR)g transcription factors, respectively. Concomitantly, mTORC1 blocks autophagy and fatty acid
oxidation via transcription factor EB (TFEB) and PPARa inhibition, respectively. In the fasted state (lower panel), lower levels of lysosomal AA, glucose, and growth factors
induce mTORC1 detachment from the lysosomal membrane and its consequent inhibition. mTORC1 inhibition in turn activates TFEB and PPARa transcription factors,
which leads to the transcriptional induction of lipophagy and b-oxidation, respectively. Concomitantly, SREBPs and PPARg are no longer activated by mTORC1, therefore
lipogenesis and adipogenesis are inhibited. Abbreviations: Rheb, Ras homolog enriched in brain; Rags, Ras-related small GTP-binding protein; SREBPs, sterol regulatory
element-binding proteins.
Review Trends in Cell Biology December 2014, Vol. 24, No. 12lipidomic studies clearly show that aged and obese mice
have an altered composition of lysosomal membrane and an
accumulation of lipids in the lysosomal lumen [70], which
could lead to abnormal lysosomal degradative capacity and
disability to fuse with other cellular structures [71,72]. The
accumulation of lipofuscin-like material in lysosomes repre-
sents a clear hallmark of aging and correlates to cellular
dysfunction. The behavior of ‘aged’ lysosomes is similar to
that associated with LSDs. In LSD cells cholesterol accu-
mulates in the lysosomal membranes and decreases the
capacity of the lysosome to fuse with other membranes by
altering soluble N-ethylmaleimide-sensitive factor attach-
ment protein (SNAP) receptors (SNAREs), which are key
components of the cellular membrane fusion machinery
[71]. It will be important to evaluate whether SNARE
function is also impaired in cells from aged or obese individ-
uals. Such lysosomal abnormalities may contribute to al-
tered mTORC1 function. Hyperactive mTORC1 can in turn
inhibit lysosome and autophagosome biogenesis, further
promoting intracellular storage of unwanted material and
lipid accumulation. This inevitably leads to a vicious cycle
that alters cellular metabolism, predisposing cells to meta-
bolic dysfunction.
Concluding remarks
During nutrient starvation lipophagy, an autophagic pro-
cess delivers lipids to the lysosome for their degradation.
Lysosomal degradation of lipids requires LAL, an enzyme
where deficiency causes massive intracellular accumula-
tion of lipids and Wolman disease. The mechanisms by
which lipophagy is regulated are currently unknown. The748increase in the mRNA level of LAL, as well as of several
lysosomal and autophagic genes, observed during starva-
tion suggests that lipophagy is a transcriptionally regulat-
ed process. Such regulation may influence the composition
of newly formed lysosomes and autophagosomes in a way
that allows them to adapt to the nature of the substrates
that need to be targeted and degraded. This observation
may be important for the identification of proteins that are
selective regulators of lipophagy, such as putative lipo-
phagy receptors.
Increasing evidence suggests that the nutrient-sensitive
TFs: TFEB, p53, and members of the FOXO family, regulate
lipophagy during fasting and that the nuclear receptor and
co-receptor family members: PPARa and PGC1a, link lipo-
phagy to other pathways involved in lipid catabolism. The
emerging view is that the cell coordinates lipid catabolism
by transcriptionally regulating lipophagy and lipid degra-
dation pathways that occur in different organelles.
Moreover, the signals that trigger lipophagy may start
from within the lysosome. The lysosome is emerging as a
sensor of cellular metabolic cues. The capacity of mTORC1
to associate to the lysosomal membrane, along with the
recent observation that members of the extracellular sig-
nal-regulated kinase (ERK) pathway localize to autopha-
gosomes [73], are both indications that the lysosomal/
autophagy pathway is a critical regulator of cellular me-
tabolism. This observation raises new important biological
questions on the role of the lysosome in regulating energy
metabolism and suggests that genetic and environmental
factors affecting lysosomal homeostasis can influence
whole-body metabolism. This concept may have a profound
Review Trends in Cell Biology December 2014, Vol. 24, No. 12impact on the development of novel therapeutic strategies
for a variety of human diseases, ranging from genetic
disorders such as LSDs to the more common metabolic
processes associated with aging and obesity. Modulation of
autophagy has already been shown to ameliorate metabol-
ic syndromes in diet- and genetic-induced preclinical mod-
els of obesity [10]. The discovery of TFEB and the
modulation of lysosome-mediated cellular clearance by
means of TFEB overexpression are examples of how regu-
lation of lysosomal function may have important implica-
tions for the development of novel therapeutic strategies.
This approach has already shown promising results in the
treatment of preclinical models of LSDs [31,32] and neuro-
degenerative disease [74]. However, more studies are need-
ed to evaluate its effectiveness and potential side effects.
Finally, drugs holding the ability to enhance lysosomal
function may represent new therapies for the treatment of
a variety of disease conditions.
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